Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - OTHER LONG-TERM ASSETS
Other Long-term Assets ADAP - Adaptimmune Therapeutics plc
3.03 M
LAST VALUE
32.72%
2 YEAR CAGR
-17.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR